Search Foundation Fighting Blindness

Displaying 611–620 of 1066 results

Jul 27, 2020

jCyte Reports Promising Results for Phase 2b Clinical Trial of its Cellular Therapy for RP

The emerging therapy is designed to work independent of the mutated gene causing vision loss

Research News
Jul 23, 2020

Zoom Meeting Tips

Zoom is a cloud-based video communications app that allows you to set up virtual video and audio conferencing, webinars, live chats, screen-sharing, and other collaborative capabilities.

Accessibility
Jul 22, 2020

AGTC Planning Phase 2/3 Clinical Trial for XLRP Gene Therapy

The company is also expanding its Phase ½ trial for the emerging treatment

Research News
Jul 22, 2020

Foundation Fighting Blindness Launches Translational Research Acceleration Program for Sight-Saving Therapies

Accepting grant applications for advancing retinal degeneration treatments toward human studies

Foundation News
Bronze Partner - Ora Clinical

Bronze Partner - Ora Clinical
Bronze Partner - MeiraGTx

Bronze Partner - MeiraGTx
Jul 17, 2020

MeiraGTx and Janssen Pharmaceuticals Report Promising Interim Results from its Phase 1/2 Clinical Trial for XLRP Gene Therapy

A Phase 3 trial for the treatment is planned

Research News
Bronze Partner - Janssen Pharmaceutical Companies

Bronze Partner - Janssen Pharmaceutical Companies
Bronze Partner - AGTC

Bronze Partner - AGTC
Gold Partner and Accessibility Underwriter - Spark Therapeutics

Gold Partner & Accessibility Underwriter Spark Therapeutics